Sandra Horning
Insider Reports History
- Location
- Foster City, CA
- Signature
- /s/ James Dillon, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Sandra Horning:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Director | Common Stock | 96,574 | $3,818,535 | $39.54 | 26 Jun 2025 | Direct |
| Moderna, Inc. | Director | Common Stock | 18,585 | $944,118 | $50.80 | 30 Apr 2026 | Direct |
| GILEAD SCIENCES, INC. | Director | Common Stock | 6,293 | $877,055 | $139.37 | 30 Apr 2026 | Direct |
| GILEAD SCIENCES, INC. | Director | Restricted Stock Unit | 7,801 | $509,171 | $65.27 | 08 May 2024 | Direct |
| Moderna, Inc. | Director | Restricted Stock Units | 2,092 | $111,017 | $113.40 | 06 May 2026 | Direct |
| Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 24,150 | 11 Jun 2025 | Direct | ||
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 12,648 | 08 May 2024 | Direct | ||
| Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 11,574 | 26 Jun 2025 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 9,681 | 06 May 2026 | Direct | ||
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 4,884 | 30 Apr 2026 | Direct | ||
| EQRx, Inc. | Director | Common Stock | 0 | $2.21 | 09 Nov 2023 | Direct | |
| EQRx, Inc. | Director | Earn-out Shares | 0 | 09 Nov 2023 | Direct | ||
| EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Nov 2023 | Direct |